- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
J B Chemicals and Pharmaceuticals Ltd (JBCH)
Discover who owns J.B. Chemicals&Pharma. Access the ownership overview, view the top J.B. Chemicals&Pharma shareholders, institutional holders, and leading mutual fund investors. Understand the key stakeholders and the distribution of JBCH shares among major financial entities.
1,692.40
+21.45(+1.28%)
Delayed Data·
Fair Value
An estimate of a J B Chemicals and Pharmaceuticals Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,661.50
1,695.05
52 wk Range
1,303.00
1,998.00
JBCH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a J B Chemicals and Pharmaceuticals Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,661.501,695.05
52 wk Range
1,303.001,998.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
JBCH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a J B Chemicals and Pharmaceuticals Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
2,019.08
Upside
+19.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
J B Chemicals and Pharmaceuticals Ltd Company Profile
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
Compare JBCH to Peers and Sector
Metrics to compare | JBCH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJBCHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.2x | 33.0x | −0.7x | |
PEG Ratio | 2.27 | 1.00 | 0.00 | |
Price/Book | 7.6x | 5.8x | 2.6x | |
Price / LTM Sales | 6.5x | 5.5x | 3.4x | |
Upside (Analyst Target) | 20.9% | 16.8% | 37.6% | |
Fair Value Upside | Unlock | −5.2% | 5.3% | Unlock |
Analyst Ratings
9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,019.08
(+19.30% Upside)
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
13.70 / 13.20
Revenue / Forecast
10.94B / 11.09B
People Also Watch
FAQ
What Stock Exchange Does J B Chemicals and Pharmaceuticals Ltd Trade On?
J B Chemicals and Pharmaceuticals Ltd is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for J B Chemicals and Pharmaceuticals Ltd?
The stock symbol for J B Chemicals and Pharmaceuticals Ltd is "JBCH."
What Is the J B Chemicals and Pharmaceuticals Ltd Market Cap?
As of today, J B Chemicals and Pharmaceuticals Ltd market cap is 264.79B.
What Is J B Chemicals and Pharmaceuticals Ltd's Earnings Per Share (TTM)?
The J B Chemicals and Pharmaceuticals Ltd EPS (TTM) is 43.15.
When Is the Next J B Chemicals and Pharmaceuticals Ltd Earnings Date?
J B Chemicals and Pharmaceuticals Ltd will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is JBCH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has J B Chemicals and Pharmaceuticals Ltd Stock Split?
J B Chemicals and Pharmaceuticals Ltd has split 2 times.
How Many Employees Does J B Chemicals and Pharmaceuticals Ltd Have?
J B Chemicals and Pharmaceuticals Ltd has 5304 employees.
What is the current trading status of J B Chemicals and Pharmaceuticals Ltd (JBCH)?
As of 17 Oct 2025, J B Chemicals and Pharmaceuticals Ltd (JBCH) is trading at a price of 1,692.40, with a previous close of 1,670.95. The stock has fluctuated within a day range of 1,661.50 to 1,695.05, while its 52-week range spans from 1,303.00 to 1,998.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.